Variant report

Variant	esv32963
Chromosome Location	chr3:160555238-160603116
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:215)
CpG islands
(count:551)
Chromatin interactive
region (count:10)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:215 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr3:160588178-160588432	K562	blood:	n/a	n/a
2	BRCA1	chr3:160587657-160587929	Hela-S3	cervix:	n/a	n/a
3	CEBPB	chr3:160587406-160588174	MCF-7	breast:	n/a	chr3:160587930-160587942
4	CEBPB	chr3:160587468-160588090	MCF-7	breast:	n/a	chr3:160587930-160587942
5	CEBPB	chr3:160587553-160588418	Hela-S3	cervix:	n/a	chr3:160587930-160587942
6	CHD2	chr3:160587636-160588004	Hela-S3	cervix:	n/a	n/a
7	CTCF	chr3:160559263-160559591	GM12878	blood:	n/a	n/a
8	CTCF	chr3:160601420-160601570	GM12864	blood:	n/a	n/a
9	CTCF	chr3:160601360-160601510	HBMEC	blood vessel:	n/a	n/a
10	CTCF	chr3:160601440-160601590	GM12864	blood:	n/a	n/a
11	CTCF	chr3:160601460-160601610	SAEC	small airway:	n/a	n/a
12	CTCF	chr3:160599737-160599837	MCF-7	breast:	n/a	n/a
13	CTCF	chr3:160601360-160601510	HCT-116	colon:	n/a	n/a
14	CTCF	chr3:160601420-160601570	NHEK	skin:	n/a	n/a
15	CTCF	chr3:160559382-160559451	GM12878	blood:	n/a	n/a
16	CTCF	chr3:160559380-160559530	BE2_C	brain:	n/a	n/a
17	CTCF	chr3:160601460-160601610	BE2_C	brain:	n/a	n/a
18	CTCF	chr3:160559354-160559484	Medullo	brain:	n/a	n/a
19	CTCF	chr3:160601400-160601550	GM06990	blood:	n/a	n/a
20	CTCF	chr3:160594220-160594370	GM06990	blood:	n/a	n/a
21	CTCF	chr3:160601520-160601670	GM12870	blood:	n/a	n/a
22	CTCF	chr3:160559246-160559654	MCF-7	breast:	n/a	n/a
23	CTCF	chr3:160601560-160601710	HMF	breast:	n/a	n/a
24	CTCF	chr3:160559361-160559494	MCF-7	breast:	n/a	n/a
25	CTCF	chr3:160601500-160601650	NHEK	skin:	n/a	n/a
26	CTCF	chr3:160601500-160601650	HCFaa	heart:	n/a	n/a
27	CTCF	chr3:160566960-160567110	BE2_C	brain:	n/a	chr3:160567008-160567017
28	CTCF	chr3:160601380-160601530	MCF-7	breast:	n/a	n/a
29	CTCF	chr3:160601460-160601610	GM12872	blood:	n/a	n/a
30	CTCF	chr3:160559380-160559447	GM10266	blood:	n/a	n/a
31	CTCF	chr3:160601420-160601570	GM12874	blood:	n/a	n/a
32	CTCF	chr3:160574400-160574550	GM06990	blood:	n/a	n/a
33	CTCF	chr3:160601380-160601530	GM12864	blood:	n/a	n/a
34	CTCF	chr3:160601420-160601570	GM12878	blood:	n/a	n/a
35	CTCF	chr3:160559398-160559461	MCF-7	breast:	n/a	n/a
36	CTCF	chr3:160559394-160559453	LNCaP	prostate:	n/a	n/a
37	CTCF	chr3:160559364-160559456	GM10248	blood:	n/a	n/a
38	CTCF	chr3:160601460-160601610	AoAF	blood vessel:	n/a	n/a
39	CTCF	chr3:160601480-160601630	GM12875	blood:	n/a	n/a
40	CTCF	chr3:160601500-160601650	GM12873	blood:	n/a	n/a
41	CTCF	chr3:160599728-160599834	H1-hESC	embryonic stem cell:	n/a	n/a
42	CTCF	chr3:160601420-160601570	HPAF	blood vessel:	n/a	n/a
43	CTCF	chr3:160599800-160599950	BE2_C	brain:	n/a	n/a
44	CTCF	chr3:160601400-160601550	HPF	lung:	n/a	n/a
45	CTCF	chr3:160601400-160601550	GM12875	blood:	n/a	n/a
46	CTCF	chr3:160601520-160601670	GM12873	blood:	n/a	n/a
47	CTCF	chr3:160601400-160601550	HAc	cerebellar:	n/a	n/a
48	CTCF	chr3:160602040-160602190	GM12872	blood:	n/a	n/a
49	CTCF	chr3:160601380-160601530	GM12873	blood:	n/a	n/a
50	CTCF	chr3:160601440-160601590	GM12871	blood:	n/a	n/a

(count:551 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:160569628-160569678	SK-N-SH_RA	brain:	n/a
2	chr3:160587737-160587787	SK-N-SH	brain:	n/a
3	chr3:160569628-160569678	SK-N-SH_RA	brain:	n/a
4	chr3:160587737-160587787	SK-N-SH	brain:	n/a
5	chr3:160588268-160588318	PFSK-1	brain:	n/a
6	chr3:160587737-160587787	HCT-116	colon:	n/a
7	chr3:160569628-160569678	BJ	skin:	n/a
8	chr3:160580380-160580430	HCT-116	colon:	n/a
9	chr3:160587737-160587787	HCPEpiC	choroid plexus:	n/a
10	chr3:160586959-160587009	AG04450	lung:	fetal
11	chr3:160586959-160587009	BE2_C	brain:	n/a
12	chr3:160558715-160558765	BE2_C	brain:	n/a
13	chr3:160569628-160569678	HCM	heart:	n/a
14	chr3:160586959-160587009	GM12891	blood:	n/a
15	chr3:160586959-160587009	LNCaP	prostate:	n/a
16	chr3:160586959-160587009	HUVEC	blood vessel:	n/a
17	chr3:160569628-160569678	ECC-1	luminal epithelium:	n/a
18	chr3:160558715-160558765	NB4	blood:	n/a
19	chr3:160586959-160587009	HCM	heart:	n/a
20	chr3:160580235-160580285	NH-A	brain:	n/a
21	chr3:160587737-160587787	AG09309	skin:	n/a
22	chr3:160580380-160580430	ProgFib	skin:	n/a
23	chr3:160569628-160569678	ovcar-3	ovarian:	n/a
24	chr3:160559936-160559986	ECC-1	luminal epithelium:	n/a
25	chr3:160569628-160569678	GM12878	blood:	n/a
26	chr3:160558715-160558765	LNCaP	prostate:	n/a
27	chr3:160586959-160587009	ovcar-3	ovarian:	n/a
28	chr3:160580235-160580285	HCT-116	colon:	n/a
29	chr3:160580264-160580314	AG09319	gingival:	n/a
30	chr3:160580235-160580285	HRE	kidney:	n/a
31	chr3:160587737-160587787	H1-hESC	embryonic stem cell:	embryo
32	chr3:160558715-160558765	Hepatocyte	liver:	n/a
33	chr3:160558715-160558765	HCT-116	colon:	n/a
34	chr3:160558715-160558765	Caco-2	colon:	n/a
35	chr3:160559936-160559986	GM12891	blood:	n/a
36	chr3:160580264-160580314	LNCaP	prostate:	n/a
37	chr3:160569628-160569678	LNCaP	prostate:	n/a
38	chr3:160586959-160587009	NHBE	bronchial:	n/a
39	chr3:160558715-160558765	HRPEpiC	eye:	n/a
40	chr3:160559936-160559986	SK-N-MC	brain:	n/a
41	chr3:160580235-160580285	HCPEpiC	choroid plexus:	n/a
42	chr3:160580380-160580430	HCM	heart:	n/a
43	chr3:160586959-160587009	NHDF-neo	bronchial:	n/a
44	chr3:160558715-160558765	H1-hESC	embryonic stem cell:	embryo
45	chr3:160587737-160587787	ProgFib	skin:	n/a
46	chr3:160586959-160587009	H1-hESC	embryonic stem cell:	embryo
47	chr3:160580264-160580314	HEEpiC	esophagus:	n/a
48	chr3:160580235-160580285	HEK293	kidney:	embryo
49	chr3:160587737-160587787	PANC-1	pancreas:	n/a
50	chr3:160559936-160559986	HRE	kidney:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:160565743..160567355-chr3:160576149..160578877,2	MCF-7	breast:
2	chr3:160588085..160590445-chr3:160591507..160593478,2	K562	blood:
3	chr3:160584041..160586531-chr3:161100253..161101953,2	K562	blood:
4	chr3:160585047..160587400-chr3:160591174..160594154,2	K562	blood:
5	chr3:160471535..160474901-chr3:160581233..160583814,3	MCF-7	breast:
6	chr3:160585047..160587400-chr3:160591174..160594154,2	K562	blood:
7	chr3:160532424..160534589-chr3:160584064..160586211,2	MCF-7	breast:
8	chr3:160565743..160567355-chr3:160576149..160578877,2	MCF-7	breast:
9	chr3:160471557..160473461-chr3:160592163..160595089,2	K562	blood:
10	chr3:160587600..160589495-chr3:161088974..161091016,2	MCF-7	breast:

No data

Variant related genes	Relation type
PPM1L	TF binding region
PPM1L	CpG island
ENSG00000260572	chromatin interactions
ENSG00000163590	chromatin interactions
ENSG00000196542	chromatin interactions

Extended variants
information (count: 1707 )
Associated
traits (count: 57 )

Variant overlapped rSNPs/rCNVs (count:1707 , 50 per page) page: 1 2 3 4 5 6 7 ... 35

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs145744522	chr3:160555244-160555245	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs372971761	chr3:160555247-160555248	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs62270263	chr3:160555306-160555307	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs34229465	chr3:160555316-160555317	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs375977693	chr3:160555341-160555342	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs141569935	chr3:160555364-160555365	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs145326560	chr3:160555390-160555391	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs147853424	chr3:160555398-160555399	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs141426105	chr3:160555409-160555410	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs182839849	chr3:160555430-160555431	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs143573513	chr3:160555455-160555456	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs187715102	chr3:160555491-160555492	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs148027859	chr3:160555544-160555545	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs567397700	chr3:160555545-160555546	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs529413065	chr3:160555566-160555567	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs74477548	chr3:160555588-160555589	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs79300295	chr3:160555606-160555607	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs576317608	chr3:160555632-160555633	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs538905543	chr3:160555656-160555657	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs140793907	chr3:160555657-160555658	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs572307459	chr3:160555663-160555664	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs541456009	chr3:160555698-160555699	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs561222409	chr3:160555715-160555716	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs150118035	chr3:160555720-160555721	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs531515954	chr3:160555739-160555740	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs543593391	chr3:160555754-160555755	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs58218216	chr3:160555791-160555792	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs563506801	chr3:160555799-160555800	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs532589911	chr3:160555853-160555854	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs546041424	chr3:160555981-160555982	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs192846522	chr3:160555986-160555987	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs527283257	chr3:160555987-160555988	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs184868118	chr3:160555996-160555997	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs138568367	chr3:160556004-160556005	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs529851272	chr3:160556036-160556037	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs141534832	chr3:160556067-160556068	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs569818965	chr3:160556129-160556130	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs538843697	chr3:160556160-160556161	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs372703264	chr3:160556201-160556202	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs187370212	chr3:160556235-160556236	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs534686926	chr3:160556338-160556339	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs142695996	chr3:160556339-160556340	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs192201134	chr3:160556345-160556346	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs574754888	chr3:160556369-160556370	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs543485112	chr3:160556373-160556374	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs368573545	chr3:160556439-160556440	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs569886391	chr3:160556442-160556443	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs530812328	chr3:160556468-160556469	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs371590440	chr3:160556559-160556560	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs146180443	chr3:160556571-160556572	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:57)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Hepatocellular carcinoma	16750200	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16608533	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Acute myeloid leukemia	20729466	CNVD
Non-small cell lung cancer	19010865	CNVD
abnormal development	18461090	CNVD
Prostate cancer	18632612	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16547154	CNVD
Breast cancer	21364760	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Effusion lymphoma	18079361	CNVD
Prostate cancer	16573809	CNVD
Breast cancer	21785460	CNVD
Bladder cancer	21909424	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	21811512	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:278 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:160550200-160558600	Weak transcription	Psoas Muscle	Psoas
2	chr3:160553400-160557800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
3	chr3:160553600-160556400	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr3:160553800-160556600	Enhancers	Primary hematopoietic stem cells short term culture	blood
5	chr3:160553800-160556800	Enhancers	Dnd41	blood
6	chr3:160554200-160555800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
7	chr3:160554200-160556200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr3:160554200-160556200	Enhancers	Primary T cells from cord blood	blood
9	chr3:160554200-160556800	Enhancers	Primary hematopoietic stem cells	blood
10	chr3:160554400-160556200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr3:160554600-160555600	Enhancers	Hela-S3	cervix
12	chr3:160554600-160556000	Enhancers	Rectal Mucosa Donor 31	rectum
13	chr3:160555000-160556200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
14	chr3:160555200-160555600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
15	chr3:160555200-160555600	Enhancers	Sigmoid Colon	Sigmoid Colon
16	chr3:160555200-160555600	Enhancers	Skeletal Muscle Female	skeletal muscle
17	chr3:160555200-160555600	Enhancers	Stomach Mucosa	stomach
18	chr3:160555200-160556000	Enhancers	Fetal Kidney	kidney
19	chr3:160555200-160556200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
20	chr3:160555400-160555600	Enhancers	Rectal Smooth Muscle	rectum
21	chr3:160555400-160555800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
22	chr3:160555400-160556000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
23	chr3:160555400-160556000	Enhancers	Rectal Mucosa Donor 29	rectum
24	chr3:160555600-160556800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
25	chr3:160555600-160560000	Weak transcription	Skeletal Muscle Female	skeletal muscle
26	chr3:160556200-160557000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
27	chr3:160557800-160558200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
28	chr3:160558200-160558400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
29	chr3:160558400-160558800	Active TSS	Breast Myoepithelial Primary Cells	Breast
30	chr3:160558400-160565400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
31	chr3:160558600-160559200	Enhancers	Psoas Muscle	Psoas
32	chr3:160558800-160560400	Enhancers	Stomach Smooth Muscle	stomach
33	chr3:160559200-160559600	Weak transcription	Psoas Muscle	Psoas
34	chr3:160559400-160560200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
35	chr3:160559600-160560400	Enhancers	Psoas Muscle	Psoas
36	chr3:160559800-160561200	Enhancers	Skeletal Muscle Male	skeletal muscle
37	chr3:160560000-160560400	Enhancers	Fetal Muscle Leg	muscle
38	chr3:160560000-160560600	Enhancers	Colon Smooth Muscle	Colon
39	chr3:160560000-160560800	Enhancers	Skeletal Muscle Female	skeletal muscle
40	chr3:160560200-160563800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
41	chr3:160560400-160566400	Weak transcription	Psoas Muscle	Psoas
42	chr3:160560800-160565200	Weak transcription	Skeletal Muscle Female	skeletal muscle
43	chr3:160561200-160565400	Weak transcription	Skeletal Muscle Male	skeletal muscle
44	chr3:160563800-160564800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
45	chr3:160565200-160565800	Enhancers	Skeletal Muscle Female	skeletal muscle
46	chr3:160565400-160565800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
47	chr3:160565400-160566400	Enhancers	Skeletal Muscle Male	skeletal muscle
48	chr3:160565800-160570800	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
49	chr3:160566400-160568400	Enhancers	Psoas Muscle	Psoas
50	chr3:160566800-160569000	Weak transcription	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links